Detection of Eber-1 RNA in primary brain lymphomas in immunocompetent and immunocompromised patients
- 28 Downloads
Tissue from primary central nervous system lymphoma (PCNSL) which developed in five patients with acquired immuno deficiency syndrome (AIDS), nine patients without immunodeficiency, and two Epstein-Barr virus (EBV)-positive control cell lines (B95-8 and Raji) were examined for the presence of EBER-1 RNA. The tissues were hybridized with digoxigenin-labeled sense or anti-sense EBER-1 riboprobes. In all five AIDS-related PCNSLs, strong hybridization signals were found with the EBER-1 anti-sense probe. Signals could be eliminated by preincubation of the tissues with RNase-A. Hybridization with the EBER-1 sense probe showed no signal. All PCNSLs from immunocompetent patients (five paraffin-embedded, four frozen) showed no hybridization signals with EBER-1 sense or antisense probe but good hybridization signals with probes to immunoglobulin kappa or lambda light chain indicating RNA preservation. The paraffin-embedded B95-8-positive control cell-line showed positive hybridization in most cells with the anti-sense EBER-1 probe, and up to one percent of the cells had a weak signal with the sense probe. Most Raji cells showed a uniform signal with the anti-sense EBER-1 probe only. We conclude that, PCNSLs that arise in AIDS patients are associated with latent EBV infections, whereas PCNSLs from immunocompetent patients are not indicating a probable role for EBV in pathogenesis of these tumors.
Key wordslymphoma central nervous system lymphoma Epstein-Barr virus acquired immuno deficinecy syndrome EBER-1
Unable to display preview. Download preview PDF.
- 5.Bashir R, Harris N, Hochberg Fet al.: Detection of Epstein-Barr virus in primary CNS lymphoma in immunocompromised patients. Neurol 39: 813–817, 1989Google Scholar
- 7.Rouah E, Rogers BB, Wilson DRet al.: Demonstration of Epstein-Barr virus in primary central nervous system lymphomas by the polymerase chain reaction andin situ hybridization. Human Path 21: 545–550, 1990Google Scholar
- 16.Chang KL, Flaris N, Hickey WF, Johnson RM, Meyer JS, Weiss LM: Brain lymphomas of immunocompetent and immunocompromised patients: study of the association with Epstein-Barr virus. Modern Path 6: 427–432, 1993Google Scholar
- 19.Non-Hodgkin's lymphoma pathologic classification project: National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and of a working formulation for clinical usage. Cancer 49: 2115, 1982Google Scholar
- 20.Bashir R, Coakham H, Hochberg F: Expression of LFA-1/ICAM-1 in CNS lymphomas: possible mechanism for lymphoma homing into the brain. J Neuro-Oncology 12: 103–110, 1992Google Scholar
- 21.Bashir R, Freedman A, Harris N, Bain K, Nadler L, Hochberg F: Immunophenotypic profile of CNS lymphoma: a review of eighteen cases. J Neuro-Oncology 7: 249–254, 1989Google Scholar
- 25.Medawar PB: Immunity to homologous grafted skin: II. The fate of skin homografts transplanted to the brain, to subcutaneous tissue and to the anterior chamber of the eye. Br J Exp Pathol 29: 58–64, 1948Google Scholar
- 27.Wekerle H, Linington C, Lassmann H, Meyermann R: Cellular immune reactivity within the CNS. TINS 9: 271–277, 1986Google Scholar